Rohinton S Tarapore (Rohinton Tarapore)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer discovery

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Isabel C Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen, Tracy T Batchelor, Nicholas A Butowski, Clark C Chen, Timothy F Cloughesy, Andrew Cluster, John de Groot, Karan S Dixit, Jerome J Graber, Aya M Haggiagi, Rebecca A Harrison, Albert Kheradpour, Lindsay B Kilburn, Sylvia C Kurz, Guangrong Lu, Tobey J MacDonald, Minesh P Mehta, Allen S Melemed, Phioanh Leia Nghiemphu, Samuel C Ramage, Nicole A Shonka, Ashley L Sumrall, Rohinton S Tarapore, Lynne P Taylor, Yoshie Umemura, Patrick Yung Wen
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology 26 (Supplement_2) (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology 26 (Supplement_2) (2024)
Isabel C Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen, Tracy T Batchelor, Nicholas A Butowski, Clark C Chen, Timothy F Cloughesy, Andrew Cluster, John de Groot, Karan S Dixit, Jerome J Graber, Aya M Haggiagi, Rebecca A Harrison, Albert Kheradpour, Lindsay B Kilburn, Sylvia C Kurz, Guangrong Lu, Tobey J MacDonald, Minesh P Mehta, Allen S Melemed, Phioanh Leia Nghiemphu, Samuel C Ramage, Nicole A Shonka, Ashley L Sumrall, Rohinton S Tarapore, Lynne P Taylor, Yoshie Umemura, Patrick Yung Wen
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology 26 (Supplement_2) (2024)
Isabel C Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen, Tracy T Batchelor, Nicholas A Butowski, Clark C Chen, Timothy F Cloughesy, Andrew Cluster, John de Groot, Karan S Dixit, Jerome J Graber, Aya M Haggiagi, Rebecca A Harrison, Albert Kheradpour, Lindsay B Kilburn, Sylvia C Kurz, Guangrong Lu, Tobey J MacDonald, Minesh P Mehta, Allen S Melemed, Phioanh Leia Nghiemphu, Samuel C Ramage, Nicole A Shonka, Ashley L Sumrall, Rohinton S Tarapore, Lynne P Taylor, Yoshie Umemura, Patrick Yung Wen
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro-oncology 26 (Supplement_2) (2024)
Isabel C Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen, Tracy T Batchelor, Nicholas A Butowski, Clark C Chen, Timothy F Cloughesy, Andrew Cluster, John de Groot, Karan S Dixit, Jerome J Graber, Aya M Haggiagi, Rebecca A Harrison, Albert Kheradpour, Lindsay B Kilburn, Sylvia C Kurz, Guangrong Lu, Tobey J MacDonald, Minesh P Mehta, Allen S Melemed, Phioanh Leia Nghiemphu, Samuel C Ramage, Nicole A Shonka, Ashley L Sumrall, Rohinton S Tarapore, Lynne P Taylor, Yoshie Umemura, Patrick Yung Wen
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Isabel C Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen, Tracy T Batchelor, Nicholas A Butowski, Clark C Chen, Timothy F Cloughesy, Andrew Cluster, John de Groot, Karan S Dixit, Jerome J Graber, Aya M Haggiagi, Rebecca A Harrison, Albert Kheradpour, Lindsay B Kilburn, Sylvia C Kurz, Guangrong Lu, Tobey J MacDonald, Minesh P Mehta, Allen S Melemed, Phioanh Leia Nghiemphu, Samuel C Ramage, Nicole A Shonka, Ashley L Sumrall, Rohinton S Tarapore, Lynne P Taylor, Yoshie Umemura, Patrick Yung Wen
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Yazmin Odia, Carl J Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Jeffrey Allen, Doured Daghistani, Matthew Hall, Ziad Khatib, Cassie N Kline, Tobey J MacDonald, Sabine Mueller, Shamia L Faison, Joshua E Allen, Odin J Naderer, Samuel C Ramage, Rohinton S Tarapore, Susan Lynne McGovern, Soumen Khatua, Wafik Zaky, Sharon L Gardner
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3K27M-mutant glioma. Neuro-oncology (2024)
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M Waszak, Stefan R Sweha, Mateus Mota, Matthew Pun, Akash Deogharkar, Chan Chung, Rohinton S Tarapore, Samuel Ramage, Andrew S Chi, Patrick Yung Wen, Isabel C Arrillaga-Romany, Tracy T Batchelor, Nicholas A Butowski, Ashley L Sumrall, Nicole A Shonka, Rebecca A Harrison, John de Groot, Minesh P Mehta, Matthew D Hall, Doured Daghistani, Timothy F Cloughesy, Benjamin M Ellingson, Kevin Beccaria, Pascale Varlet, Michelle M Kim, Yoshie Umemura, Hugh J L Garton, Andrea T Flynn, Jonathan Schwartz, Rajan Jain, Maureen Kachman, Heidi Baum, Charles F Burant, Sophie L Mottl, Rodrigo T Cartaxo, Vishal John, Dana Messinger, Tingting Qin, Erik R Peterson, Peter Sajjakulnukit, Karthik Ravi, Alyssa Waugh, Dustin Walling, Yujie Ding, Ziyun Xia, Anna A Schwendeman, Debra Hawes, Fusheng Yang, Alexander R Judkins, Daniel R Wahl, Costas Andreas Lyssiotis, Daniel de la Nava, Marta Marija Alonso, Augustine Eze, Jasper Spitzer, Susanne Viktoria Schmidt, Ryan J Duchatel, Matthew D Dun, Jason E Cain, Li Jiang, Sylwia A Stopka, Gerard Baquer, Michael S Regan, Mariella G Filbin, Nathalie Y R Agar, Lili Zhao, Chandan Kumar-Sinha, Rajen J Mody, Arul M Chinnaiyan, Ryo Kurokawa, Sriram Venneti, Viveka N Yadav, Jacques Grill, Cassie N Kline, Romain Mueller, Adam C Resnick, Javad Nazarian, Joshua E Allen, Yazmin Odia, Sharon L Gardner, Carl J Koschmann
Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways. Cancer discovery (2023)
Sharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, Susan L McGovern, Wafik Zaky, Yazmin Odia, Doured Daghistani, Zuanel Diaz, Matthew D Hall, Ziad Khatib, Carl J Koschmann, Evan Cantor, Ryo Kurokawa, Tobey J MacDonald, Dolly Aguilera, Nicholas A Vitanza, Sabine Mueller, Cassie Kline, Guangrong Lu, Joshua E Allen, Soumen Khatua
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. Neuro-oncology advances 4 (1) (2022)